Last reviewed · How we verify
NCT03831412
Cognitive Behavioral Therapy for Insomnia vs. Exposure, Relaxation, and Rescripting Therapy
NA trial testing CBT-I in Insomnia in 13 participants. Completed in 31 January 2021.
31 January 2021
Quick facts
| Lead sponsor | University of Tulsa |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 13 |
| Start date | 1 August 2017 |
| Primary completion | 31 January 2021 |
| Estimated completion | 31 January 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CBT-I
- ERRT
Conditions studied
- Insomnia — all drugs for Insomnia →
- Nightmare — all drugs for Nightmare →
- Trauma — all drugs for Trauma →
Sponsor
University of Tulsa
Who can join
Adults 18 to 99, any sex, with Insomnia or Nightmare. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this project is to determine if directly addressing disturbed sleep and nightmares will impact client reports of suicidal ideation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03831412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CBT-I
Trials testing the same drug.
- NCT07333586 — Insomnia and Insulin Resistance · NA · not yet recruiting
- NCT07279168 — Investigation of the Effectiveness of Virtual Reality (VR) Hypnosis in Improving Poor Sleep Among Chinese Childhood Canc · NA · not yet recruiting
- NCT07091149 — Digital Cognitive Behavioral Treatment of Insomnia in Youth: An RCT Examining Feasibility, Acceptability, and Efficacy o · NA · recruiting
- NCT06749444 — Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia · NA · recruiting
- NCT06156306 — CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety · NA · recruiting
Other recruiting trials for Insomnia
Currently open trials in the same condition.
- NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
- NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
- NCT07071324 — CF Wellness Program · NA · recruiting
- NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
- NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting
Other University of Tulsa trials
Trials by the same sponsor.
- NCT03600532 — Teachable Moment Brief Intervention for Suicide Attempt Survivors in an Inpatient Setting · NA · terminated
- NCT03722043 — Investigating the Impact of A Veteran-Focused Parenting Program on Parenting Stress, Competence and Parenting Practices · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03831412 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tulsa
- Last refreshed: 27 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03831412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing